Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Hovgaard

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
International Journal of Pharmaceutics|January 10, 2025
To conjugate or not to conjugate? evaluating the potential use of cell-penetrating peptides for conjugation or complexation with oligonucleotides by surface plasmon resonanceRikke Dueholm, Jakob Ewald, Franziska Zosel, et al.
Acta Pharmaceutica Sinica. B|May 9, 2022
The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin deliveryJingyi Li, Yaqi Zhang, Miaorong Yu, et al.
Acta Pharmaceutica Sinica. B|July 14, 2025
Erratum: Author correction to "The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery" [Acta Pharm Sin B 12 (2022) 1460-1472]Jingyi Li, Yaqi Zhang, Miaorong Yu, et al.
Journal of Pharmaceutical Sciences|September 12, 2007
Solvent diversity in polymorph screeningMorten Allesø, Frans van den Berg, Claus Cornett, et al.
Cell Reports. Medicine|November 22, 2023
Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes managementAndrea I d'Aquino, Caitlin L Maikawa, Leslee T Nguyen, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of DiabetesAndrea I d'Aquino, Caitlin L Maikawa, Leslee T Nguyen, et al.
Journal of Medicinal Chemistry|December 28, 2020
Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320Thomas B Kjeldsen, František Hubálek, Tina M Tagmose, et al.
Nature Communications|July 29, 2020
Molecular engineering of safe and efficacious oral basal insulinFrantisek Hubálek, Hanne H F Refsgaard, Sanne Gram-Nielsen, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
International Journal of Pharmaceutics|January 10, 2025
To conjugate or not to conjugate? evaluating the potential use of cell-penetrating peptides for conjugation or complexation with oligonucleotides by surface plasmon resonanceRikke Dueholm, Jakob Ewald, Franziska Zosel, et al.
Acta Pharmaceutica Sinica. B|May 9, 2022
The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin deliveryJingyi Li, Yaqi Zhang, Miaorong Yu, et al.
Acta Pharmaceutica Sinica. B|July 14, 2025
Erratum: Author correction to "The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery" [Acta Pharm Sin B 12 (2022) 1460-1472]Jingyi Li, Yaqi Zhang, Miaorong Yu, et al.
Journal of Pharmaceutical Sciences|September 12, 2007
Solvent diversity in polymorph screeningMorten Allesø, Frans van den Berg, Claus Cornett, et al.
Cell Reports. Medicine|November 22, 2023
Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes managementAndrea I d'Aquino, Caitlin L Maikawa, Leslee T Nguyen, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of DiabetesAndrea I d'Aquino, Caitlin L Maikawa, Leslee T Nguyen, et al.
Journal of Medicinal Chemistry|December 28, 2020
Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320Thomas B Kjeldsen, František Hubálek, Tina M Tagmose, et al.
Nature Communications|July 29, 2020
Molecular engineering of safe and efficacious oral basal insulinFrantisek Hubálek, Hanne H F Refsgaard, Sanne Gram-Nielsen, et al.
Pageof 4